, Tracking Stock Market Picks
Enter Symbol:
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

up 56.64 %

Acorda Therapeutics, Inc. (ACOR) rated Outperform with price target $38 by RBC Capital Mkts

Posted on: Wednesday,  Apr 20, 2011  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Acorda Therapeutics, Inc. (NASDAQ: ACOR) on 04/20/2011. Previously RBC Capital Mkts rated Outperform Acorda Therapeutics, Inc. (NASDAQ: ACOR)
on 11/07/2008., when the stock price was $20.23. Since then, Acorda Therapeutics, Inc. has gained 56.65% as of 01/26/2016's recent price of $31.69.
If you would have followed the previous RBC Capital Mkts's recommendation on ACOR, you would have gained 56.64% of your investment in 2636 days.

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/20/2011 9:25 AM Buy
28.39 38.00
as of 12/30/2011
1 Week up  1.66 %
1 Month up  2.98 %
3 Months up  19.43 %
1 YTD down  -12.54 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/15/2010 9:25 AM Buy
39.35 40.00
2/17/2010 10:25 AM Buy
31.73 36.00
11/7/2008 10:25 AM Buy
20.23 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy